Metraipolis › archive › dc_64a8decbe59a
The Impact of Antithrombotic Therapy on Bleeding Complications in Percutaneous Liver Biopsy: Are the Withdrawal Criteria of Antithrombotic Agents in Japan… — Europe PMC PMID:42346278
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42346278
- DOI
- 10.3390/diseases14060184
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T09:40:29.571Z
- SHA-256 of the archived text
0f202fe8d6455675f40129159ee3d9ccbdfbb5c4475f79f46ca80fdb5ab41bbd- Stable URL of this page
https://metraipolis.com/documento/dc_64a8decbe59a
How to cite
The Impact of Antithrombotic Therapy on Bleeding Complications in Percutaneous Liver Biopsy: Are the Withdrawal Criteria of Antithrombotic Agents in Japan… — Europe PMC PMID:42346278 — Europe PMC (en), https://europepmc.org/article/MED/42346278 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_64a8decbe59a (Metraipolis archive dc_64a8decbe59a, sha256 0f202fe8d6455675f40129159ee3d9ccbdfbb5c4475f79f46ca80fdb5ab41bbd)
BibTeX
@misc{dc64a8decbe59a,
title = {The Impact of Antithrombotic Therapy on Bleeding Complications in Percutaneous Liver Biopsy: Are the Withdrawal Criteria of Antithrombotic Agents in Japan… — Europe PMC PMID:42346278},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42346278},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_64a8decbe59a; sha256 0f202fe8d6455675f40129159ee3d9ccbdfbb5c4475f79f46ca80fdb5ab41bbd},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42346278. Agents can read the archived copy with the MCP tool read_document.